Lopci E, Aide N, Dimitrakopoulou-Strauss A, Dercle L, Iravani A, Seban RD, et al. Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [(18)F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer Imaging. 2022;22:73.

Article  PubMed  PubMed Central  Google Scholar 

Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, et al. State of the art of (18)F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging. 2021;9:299–339.

Article  PubMed  PubMed Central  Google Scholar 

Chetelat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurol. 2020;19:951–62.

Article  PubMed  Google Scholar 

Manabe O, Tamaki N. The future of cardiac disease assessment using (18)F-FDG PET/CT. Jpn J Radiol. 2021;39:511–3.

Article  PubMed  Google Scholar 

Al-Ibraheem A, Abdlkadir AS, Juweid ME, Al-Rabi K, Ma’koseh M, Abdel-Razeq H, et al. FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects. Cancers (Basel). 2023;15:1063.

Article  PubMed  Google Scholar 

Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019. Cancer Res Treat. 2022;54:330–44.

Article  PubMed  PubMed Central  Google Scholar 

Moon SH, Cho YS, Choi JY. KSNM60 in Clinical Nuclear Oncology. Nucl Med Mol Imaging. 2021;55:210–24.

Article  PubMed  PubMed Central  Google Scholar 

KOICD. KCD 7.0. In. 2010. https://www.koicd.kr/kcd/guide.do?degree=07. Accessed Oct 17, 2024

Korea S. Statistics Korea. In. 2024. https://www.index.go.kr/unity/potal/indicator/IndexInfo.do?cdNo=210&idxCd=F0002. Accessed Oct 17, 2024

Farsad M. FDG PET/CT in the Staging of Lung Cancer. Curr Radiopharm. 2020;13:195–203.

Article  PubMed  PubMed Central  Google Scholar 

Leger MA, Routy B, Juneau D. FDG PET/CT for evaluation of immunotherapy response in lung cancer patients. Semin Nucl Med. 2022;52:707–19.

Article  PubMed  Google Scholar 

Marcus C, Tajmir SH, Rowe SP, Sheikhbahaei S, Solnes LB. (18)F-FDG PET/CT for Response Assessment in Lung Cancer. Semin Nucl Med. 2022;52:662–72.

Article  PubMed  Google Scholar 

Rodriguez-Fraile M, Cozar-Santiago MP, Sabate-Llobera A, Caresia-Aroztegui AP, Delgado Bolton RC, Orcajo-Rincon J, et al. FDG PET/CT in colorectal cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020;39:57–66.

PubMed  Google Scholar 

Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, et al. PET/CT in Non-Hodgkin Lymphoma: An Update. Semin Nucl Med. 2023;53:320–51.

Article  PubMed  Google Scholar 

Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, et al. EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3. Eur J Nucl Med Mol Imaging. 2022;49:632–51.

Article  PubMed  Google Scholar 

Pijl JP, Nienhuis PH, Kwee TC, Glaudemans A, Slart R, Gormsen LC. Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation. Semin Nucl Med. 2021;51:633–45.

Article  PubMed  Google Scholar 

Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Chetelat G, Drezgza A, et al. A Cochrane review on brain [(1)(8)F]FDG PET in dementia: limitations and future perspectives. Eur J Nucl Med Mol Imaging. 2015;42:1487–91.

Article  PubMed  Google Scholar 

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, et al. The FDA-approved anti-amyloid-beta monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Med Res. 2023;28:544.

Article  PubMed  PubMed Central  Google Scholar 

Eloranta S, Smedby KE, Dickman PW, Andersson TM. Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis. J Intern Med. 2021;289:12–28.

Article  PubMed  Google Scholar 

Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, et al. Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev. 2020;29:367–81.

Article  PubMed  Google Scholar